DGX announcements Quest Diagnostics Incorporated announcements and dividends declared NYSE
Quest Diagnostics Incorporated Complete list of announcements declared & dividend announcements by Quest Diagnostics Incorporated DGX
Quest Diagnostics Incorporated DGX listed on NYSE and deals in Health Care Medical SpecialitiesAnnouncements and dividends declared by Quest Diagnostics Incorporated DGX
Quest Diagnostics (DGX) Unveils the 88-Compound NPS Test Panel
Quest Diagnostics DGX recently launched its new confirmatory testing service for novel psychoactive substances (NPS). The new panel, which tests for 88 compounds, covers a broad array of drug classes, such as designer opioids, des
Announcement as on 20 December 2023
: Quest Diagnostics profit falls 12%, but beats estimate
Quest Diagnostics Inc. DGX said Tuesday its third-quarter profit dropped by 12.2% to 5 million, or .96 a share, from 6 million, or .17 a share, in the year-ago quarter. Adjusted third-quarter profit fell to .22 a share from .36 a share, and b
Announcement as on 24 October 2023
: Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease
Quest Diagnostics Inc. DGX said Monday it has brought the first blood-based biomarker test to assess the risk of developing Alzheimer’s disease to market and it’s now available for consumer purchase. The test helps assess the risk of getting the diseas
Announcement as on 31 July 2023
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates
Quest Diagnostics (DGX) came out with quarterly earnings of .30 per share, beating the Zacks Consensus Estimate of .23 per share. This compares to earnings of .36 per share a year ago. These figures are adjusted for non-recu
Announcement as on 26 July 2023
Quest Diagnostics (DGX) Brings New Test for Prostate Cancer
Quest Diagnostics DGX recently launched a novel prostate cancer biomarker test through its subspecialty pathology business unit, AmeriPath. The laboratory test is developed in collaboration with Envision Sciences — an Australia-ba
Announcement as on 14 July 2023
Announcements by Quest Diagnostics Incorporated first page | Next page | Prev page |
DGX Quest Diagnostics Incorporated current price & indicator signals
Recent prices of DGX Quest Diagnostics Incorporated are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 08 Wed Jan 2025 | 154.03 | 151.63 to 154.28 | 0% | 1.2 times |
| 08 Wed Jan 2025 | 154.03 | 151.63 to 154.28 | 0.25% | 1.2 times |
| 07 Tue Jan 2025 | 153.64 | 152.20 to 154.00 | 0.9% | 1.16 times |
| 06 Mon Jan 2025 | 152.27 | 151.53 to 153.81 | 0.23% | 1.48 times |
| 03 Fri Jan 2025 | 151.92 | 149.92 to 152.22 | 0.64% | 1.42 times |
| 02 Thu Jan 2025 | 150.96 | 150.29 to 152.00 | 0.07% | 0.78 times |
| 31 Tue Dec 2024 | 150.86 | 150.52 to 152.48 | -0.07% | 0.87 times |
| 30 Mon Dec 2024 | 150.97 | 150.28 to 152.26 | -1.09% | 0.91 times |
| 27 Fri Dec 2024 | 152.63 | 151.89 to 153.62 | -0.25% | 0.91 times |
| 26 Thu Dec 2024 | 153.02 | 152.19 to 153.51 | -0.26% | 0.84 times |
| 24 Tue Dec 2024 | 153.42 | 152.13 to 153.49 | 0.31% | 0.41 times |
| 23 Mon Dec 2024 | 152.94 | 150.89 to 153.46 | -0.1% | 1.1 times |
Videos related to: DGX announcements Quest Diagnostics Incorporated announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance